Literature DB >> 36147786

Early reversibility of histological changes after experimental acute cardiac volume-overload.

Christa Huuskonen1, Mari Hämäläinen2, Nooa Kivikangas1, Timo Paavonen3, Eeva Moilanen2, Ari A Mennander1.   

Abstract

Unloading the heart may aid recovery after acute cardiac volume-overload (AVO). We experimentally investigated whether unloading the heart after AVO by heterotopic transplantation histologically impacts myocardial outcome. Thirty-two syngeneic Fisher 344 rats underwent surgery for abdominal arterial-venous fistula to induce AVO. Seven hearts were heterotopically transplanted one day after AVO to simulate a non-working state of the left ventricle (AVO+Tx). In addition, six rats without AVO or surgery (Normal) and five rats with sham surgery (Sham) served as controls. Myocardial outcome was studied using histology and quantitative reverse-transcription polymerase chain reaction (qRT-PCR) analysis for hypoxia inducible factor 1alpha (HIF1α), inducible nitric oxide synthase (iNOS), E-selectin, atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), vascular endothelial growth factor alpha (VEGFα), matrix metalloprotease 9 (MMP9), chitinase-3-like protein (YKL-40) and transforming growth factor beta (TGFβ). Relative ischemia of the right ventricle and septal intramyocardial arteries was decreased in AVO+Tx as compared with AVO (0.04±0.01 vs. 0.09±0.02, PSU, P=0.040 and 0.04±0.01 vs. 0.16±0.02, PSU, P=0.008, respectively). Quantitative RT-PCR showed an increase in the expression of iNOS, YKL-40 and VEGFα, and decrease in ANP in AVO+Tx as compared with AVO (5.78±1.23 vs. 2.46±0.81, P=0.039, 22.39±5.22 vs. 10.79±1.70, P=0.039 and 1.15±0.22 vs. 0.60±0.08, P=0.030, and 1.32±0.16 vs. 2.85±0.70, P=0.039, respectively). Unloading the heart by heterotopic transplantation induces early ischemic recovery of intramyocardial arteries after AVO. A non-working state reverses acute ischemic myocardial injury after AVO. AJCD
Copyright © 2022.

Entities:  

Keywords:  Acute volume-overload (AVO); heterotopic rat cardiac transplantation; intramyocardial artery; ischemia

Year:  2022        PMID: 36147786      PMCID: PMC9490159     

Source DB:  PubMed          Journal:  Am J Cardiovasc Dis        ISSN: 2160-200X


  20 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  Cardiac fibroblasts: at the heart of myocardial remodeling.

Authors:  Karen E Porter; Neil A Turner
Journal:  Pharmacol Ther       Date:  2009-05-19       Impact factor: 12.310

3.  A YKL-40-neutralizing antibody blocks tumor angiogenesis and progression: a potential therapeutic agent in cancers.

Authors:  Michael Faibish; Ralph Francescone; Brooke Bentley; Wei Yan; Rong Shao
Journal:  Mol Cancer Ther       Date:  2011-02-25       Impact factor: 6.261

Review 4.  Reverse remodeling following insertion of left ventricular assist devices (LVAD): a review of the morphological and molecular changes.

Authors:  Jeremias Wohlschlaeger; Klaus J Schmitz; Christof Schmid; Kurt W Schmid; Petra Keul; Atsushi Takeda; Serge Weis; Bodo Levkau; Hideo A Baba
Journal:  Cardiovasc Res       Date:  2005-07-18       Impact factor: 10.787

5.  Development of an in vivo ischemia-reperfusion model in heterotopically transplanted rat hearts.

Authors:  Ken Suzuki; Bari Murtuza; Ryszard T Smolenski; Noriko Suzuki; Magdi H Yacoub
Journal:  Transplantation       Date:  2002-05-15       Impact factor: 4.939

6.  Knockdown of YKL-40 inhibits angiogenesis through regulation of VEGF/VEGFR2 and ERK1/2 signaling in endometrial cancer.

Authors:  Hong-Yan Chen; Zhao-Yu Zhou; Yan-Lu Luo; Qin Luo; Jiang-Tao Fan
Journal:  Cell Biol Int       Date:  2021-10-04       Impact factor: 3.612

7.  Acute aortocaval fistula: role of low perfusion pressure and subendocardial remodeling on left ventricular function.

Authors:  Flávia R R Mazzo; Clovis de Carvalho Frimm; Ana Iochabel S Moretti; Maria C Guido; Marcia K Koike
Journal:  Int J Exp Pathol       Date:  2013-04-18       Impact factor: 1.925

8.  E-selectin and intercellular adhesion molecule-1 are released by activated human endothelial cells in vitro.

Authors:  J F Leeuwenberg; E F Smeets; J J Neefjes; M A Shaffer; T Cinek; T M Jeunhomme; T J Ahern; W A Buurman
Journal:  Immunology       Date:  1992-12       Impact factor: 7.397

9.  Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs.

Authors:  S Banai; M T Jaklitsch; M Shou; D F Lazarous; M Scheinowitz; S Biro; S E Epstein; E F Unger
Journal:  Circulation       Date:  1994-05       Impact factor: 29.690

10.  HIF1α-Induced Glycolysis Metabolism Is Essential to the Activation of Inflammatory Macrophages.

Authors:  Ting Wang; Huiying Liu; Guan Lian; Song-Yang Zhang; Xian Wang; Changtao Jiang
Journal:  Mediators Inflamm       Date:  2017-12-13       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.